Identification of Dysregulated Mechanisms and Candidate Gene Markers in Chronic Obstructive Pulmonary Disease
Jie Lin,Yanlong Xue,Wenyan Su,Zan Zhang,Qiu Wei,Tianxia Huang
DOI: https://doi.org/10.2147/COPD.S349694
2022-03-04
International Journal of COPD
Abstract:Jie Lin, 1, 2, &ast Yanlong Xue, 1, 2, &ast Wenyan Su, 1, 2, &ast Zan Zhang, 1, 2 Qiu Wei, 1, 2 Tianxia Huang 1, 2 1 Department of Respiratory and Critical Care, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People's Republic of China; 2 Department of Respiratory and Critical Care, The First People's Hospital of Nanning, Nanning, Guangxi, 530022, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiu Wei; Tianxia Huang, Department of Respiratory and Critical Care, The Fifth Affiliated Hospital of Guangxi Medical University, 89 Qixing Road, Nanning, Guangxi, 530022, People's Republic of China, Tel +86 7712636163, Fax +86 7712617892, Email ; Purpose: This study aimed to identify candidate gene markers that may facilitate chronic obstructive pulmonary disease (COPD) diagnosis and treatment. Methods: The GSE47460 and GSE151052 datasets were analyzed to identify differentially expressed mRNAs (DEmRs) between COPD patients and controls. DEmRs that were differentially expressed in the same direction in both datasets were analyzed for functional enrichment and for coexpression. Genes from the largest three modules were tested for their ability to diagnose COPD based on the area under the receiver operating characteristic curve (AUC). Genes with AUC > 0.7 in both datasets were used to perform regression based on the "least absolute shrinkage and selection operator" in order to identify feature genes. We also identified differentially expressed miRNAs (DEmiRs) between COPD patients and controls using the GSE38974 dataset, then constructed a regulatory network. We also examined associations between feature genes and immune cell infiltration in COPD, and we identified methylation markers of COPD using the GSE63704 dataset. Results: A total of 1350 genes differentially regulated in the same direction in the GSE47460 and GSE151052 datasets were found. The genes were significantly enriched in immune-related biological functions. Of 186 modules identified using MEGENA, the largest were C1_ 6, C1_ 3, and C1_ 2. Of the 22 candidate genes screened based on AUC, 11 feature genes emerged from analysis of a subset of GSE47460 data, which we validated using another subset of GSE47460 data as well as the independent GSE151052 dataset. Feature genes correlated significantly with infiltration by immune cells. The feature genes GPC4 and RS1 were predicted to be regulated by miR-374a-3p. We identified 117 candidate methylation markers of COPD, including PRRG4. Conclusion: The feature genes we identified may be potential diagnostic markers and therapeutic targets in COPD. These findings provide new leads for exploring disease mechanisms and targeted treatments. Keywords: chronic obstructive pulmonary disease, bioinformatics analysis, miRNAs, immune response, feature genes According to estimates from the Global Burden of Disease (GBD) study, 523 million around the world had cardiovascular disease in 2019. 1 Chronic obstructive pulmonary disease (COPD) is a major cause of global morbidity and mortality related to cardiovascular disease. COPD is caused by persistent, often progressive airflow limitation in the lungs, and it includes the conditions of chronic bronchitis and emphysema. 2 More than 3 million people die from COPD every year worldwide, 3 and COPD is expected to become the third leading cause of death globally by 2030. 4 Despite the worldwide prevalence of this disease, it remains largely underdiagnosed and undertreated. Many factors have been associated with COPD, including systemic and local inflammation, air pollution and smoking. 5 However, the exact mechanism of COPD remains unclear. Clinically, this disorder is characterized by cough and chronic dyspnea resulting from airway stenosis. Accumulating evidence indicates that COPD is a systemic disease, and that its pathological manifestations are not limited to lung inflammation and airway remodeling 6 In fact, COPD has a profound effect on cardiac function and gas exchange, and COPD patients are at 2–5 times greater risk of cardiovascular disease than the general population. 7 Cardiovascular disease in any stage of COPD greatly increases the risk of death and hospitalization. 8 Approximately 22–40% of COPD patients experience at least one moderate or severe exacerbation each year, and 9–16% experience more than one exacerbation per year. 9 Dyspnea is the main symptom of COPD and the most frequent reason why COPD patients se -Abstract Truncated-
English Else